Medical Doctor Program year 2024 Reported 2019–2024 Source: CMS Open Payments, 2026 publication

Franklin Moore

Anatomic Pathology & Clinical Pathology Springfield, MA Medical Doctor

NPI 1174702864 CMS profile 738660

759 Chestnut St, D1170, Springfield, MA 01199

Open in the dashboard

General payments

$49,751

33 records reported · program years 2019–2024

Research payments

$0

Paid to them · None reported · program years 2019–2024

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$975 paid to institutions, not to them · program year 2020

Through program year 2024, Franklin Moore of Springfield, MA is reported in the CMS Open Payments database as having received $49,751 across 33 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $975 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 97th percentile of Anatomic Pathology & Clinical Pathology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

4 rows
Year Kind Relative to this record's peak year Amount Records
2024 General $16 1
2021 General $3,973 2
2020 General $6,850 2
2019 General $38,912 28

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Franklin Moore
  • Anatomic Pathology & Clinical Pathology median
  • Middle half of Anatomic Pathology & Clinical Pathology
  • National median

In program year 2025, general payments to Franklin Moore were reported at $0. Among 2,804 Anatomic Pathology & Clinical Pathology profiles paid that year, the median was $51 and the middle half received between $24 and $149.

Show as a table
Year Franklin Moore Anatomic Pathology & Clinical Pathology median Middle half National median
2019 $38,912 $65 $22–$150 $163
2020 $6,850 $44 $19–$144 $114
2021 $3,973 $42 $19–$142 $132
2022 $0 $54 $20–$140 $149
2023 $0 $60 $23–$157 $160
2024 $16 $51 $23–$145 $164
2025 $0 $51 $24–$149 $169

Breakdown

Who paid General payments · program years 2019–2024
  1. AstraZeneca Pharmaceuticals LP $48,911 31 payments
  2. Roche Sequencing Solutions, Inc. $800 1 payment
  3. BioFire Diagnostics, LLC $40 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2024
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $36,690 11 payments
  2. Consulting Fee $9,983 2 payments
  3. Travel and Lodging $2,416 10 payments
  4. Food and Beverage $662 10 payments
Products named General payments · program years 2019–2024
  1. TAGRISSO $38,993 28 payments
  2. LYNPARZA $6,050 1 payment
  3. GENOMIC ANALYSIS SOFTWARE $800 1 payment
  4. IMFINZI $118 1 payment
  5. Film Array $40 1 payment

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 1 billing codes

Paid by Medicare

$21,338

Medicare's payments for the services billed

Medicare patients

407

Average age 74

Services billed

611

222 women, 185 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Cancer 46%
Arthritis 43%
COPD 37%
Chronic kidney disease 34%
Ischemic heart disease 32%
Depression 29%
Diabetes 28%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

1 product · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
TAGRISSO
  • AstraZeneca Pharmaceuticals LP $16
$16 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

33 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Anatomic Pathology & Clinical Pathology in Massachusetts

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2024

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record